Home › Funds › DV EQUITIES, LLC › NERV

DV EQUITIES, LLC position in NERV

MINERVA NEUROSCIENCES INC · Health Care

DV EQUITIES, LLC reported holding 754,397 shares of NERV (MINERVA NEUROSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$4.2M, representing 0.61% of its reported portfolio and ranking #32 among its reported holdings. DV EQUITIES, LLC first reported this position in Q2 2026.

Latest position (Q2 2026)754.40K sh
Reported value held$4.19M
Portfolio Weight0.61%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DV EQUITIES, LLC's NERV position evolved

DV EQUITIES, LLC first disclosed a stake in NERV in Q2 2026 at 754,397 shares (US$4.2M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 754.40K $4.19M New

About NERV and 13F data

NERV (MINERVA NEUROSCIENCES INC) is a Health Care company. 56 other funds we track also report a position in NERV — the largest reported positions include Vivo Capital, LLC (US$24.0M), Logos Global Management LP (US$18.3M), Ally Bridge Group (NY) LLC (US$12.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NERV

All NERV fund holders →

FAQ

How long has DV EQUITIES, LLC held NERV?

DV EQUITIES, LLC has disclosed NERV holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is DV EQUITIES, LLC's current position in NERV?

As of Q2 2026, DV EQUITIES, LLC holds 754.40K shares of NERV (MINERVA NEUROSCIENCES INC), valued at $4.19M, representing 0.61% of its reported portfolio and ranking #32.

Has DV EQUITIES, LLC been buying or selling NERV?

In the latest 13F filing (Q2 2026), DV EQUITIES, LLC newly opened its position in NERV.

Which other funds hold NERV?

Other major institutional holders of NERV include Vivo Capital, LLC, Logos Global Management LP, Ally Bridge Group (NY) LLC, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.